Xention

company

About

Xention Limited is a biopharmaceutical company specialized in the discovery and development of ion channel-modulating drugs.

  • 11 - 50

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
£4M
Industries
Biotechnology,Developer Platform,Medical
Founded date
Jan 1, 2002
Number Of Employee
11 - 50
Operating Status
Active

Xention Limited, a biopharmaceutical company, specializes in the discovery and development of ion channel-modulating drugs. It offers drugs for the treatment of atrial fibrillation, overactive bladder, pain, and autoimmune diseases. Xention Limited was formerly known as Xention Discovery Ltd. and later changed its name to Xention Limited in October 2006. The company was founded in 2002 and is based in Cambridge, the United Kingdom.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
£4M €11M
Xention has raised a total of £4M €11M in funding over 2 rounds. Their latest funding was raised on Jul 18, 2005 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 18, 2005 Series B €11M 1 Detail
Sep 10, 2003 Series Unknown £4M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Xention is funded by 1 investors. Albany Ventures Fund III are the most recent investors.
Investor Name Lead Investor Funding Round
Albany Ventures Fund III Series B